How should I interpret low hemoglobin, low hematocrit, macrocytosis (mean corpuscular volume 105 fL), elevated mean corpuscular hemoglobin (36 pg), and reduced red blood cell count?

Macrocytic Anemia with Decreased RBC Production

These laboratory values indicate macrocytic anemia (MCV 105 fL) with reduced red blood cell count, requiring immediate evaluation for vitamin B12 or folate deficiency as the most likely cause, followed by assessment for myelodysplastic syndrome, medications, alcohol use, liver disease, and hypothyroidism.

Initial Interpretation

Your results show:

• Anemia: Hb 109 g/L (low)
• Low hematocrit: 0.32 L/L
• Macrocytosis: MCV 105 fL (>100 fL defines macrocytosis) 1
• Elevated MCH: 36 pg (consistent with larger cells containing more hemoglobin)
• Reduced RBC count: 3.07 × 10¹²/L

This pattern represents macrocytic anemia with decreased red blood cell production 1.

Algorithmic Diagnostic Approach

Step 1: Order Reticulocyte Count Immediately

The reticulocyte index (RI) distinguishes production versus destruction mechanisms 1:

• Low RI (<1.0-2.0): Indicates decreased RBC production → proceed to Step 2
• High RI: Suggests hemolysis or blood loss (unlikely given your macrocytosis pattern)

Step 2: Classify Macrocytic Anemia Type

With MCV >100 fL and presumed low reticulocyte count, the differential includes 1:

Most Common Causes (>70% of cases):

1. Megaloblastic anemia (most common with MCV 105 fL):

   • Vitamin B12 deficiency (most frequent) 2, 3
   • Folate deficiency

2. Non-megaloblastic causes:

   • Medications (hydroxyurea, methotrexate, azathioprine) 1, 4
   • Alcohol abuse 5, 6
   • Liver disease 4, 5

Less Common but Critical:

• Myelodysplastic syndrome (MDS) - especially if MCV >120 fL 1, 4
• Hypothyroidism 4

Step 3: Essential Laboratory Tests

Order these tests now 1:

1. Serum vitamin B12 level - Low levels confirm B12 deficiency

2. Serum folate level - Low levels confirm folate deficiency

3. Methylmalonic acid (MMA) - Elevated in B12 deficiency even when serum B12 is borderline 1

4. Total homocysteine - Elevated in both B12 and folate deficiency 1, 5

5. Peripheral blood smear review - Look for:

   • Hypersegmented neutrophils (≥5 lobes) - present in 86% of megaloblastic cases 2
   • Macro-ovalocytes - present in 72% of megaloblastic cases 2
   • Teardrop cells suggest MDS 1

6. Liver function tests - Assess for liver disease 4, 5

7. Thyroid function tests (TSH) - Screen for hypothyroidism 4

Step 4: Clinical History Focus

Document specifically 1:

• Dietary history: Strict vegetarian/vegan diet (B12 deficiency risk)
• Alcohol consumption: Daily intake amount 5, 6
• Medications: Methotrexate, hydroxyurea, phenytoin, azathioprine, antacids, proton pump inhibitors 1, 4
• Gastrointestinal symptoms: Diarrhea, malabsorption (celiac disease, Crohn's disease, prior gastric surgery) 1
• Neurological symptoms: Paresthesias, ataxia, cognitive changes (B12 deficiency) 1
• Family history: Pernicious anemia, hematological disorders 1

Critical Decision Points

If MCV >120 fL:

Vitamin B12 deficiency is the most likely cause 5. However, MDS must be excluded if vitamin replacement fails to correct anemia within 4-8 weeks 3.

If Vitamin Levels Are Normal:

Consider 4, 5:

• Medication review (stop offending agents if possible)
• Alcohol cessation counseling
• Bone marrow biopsy if MDS suspected (especially age >55 years with refractory anemia) 3

If Combined Deficiencies Suspected:

Red cell distribution width (RDW) will be elevated, indicating mixed cell populations 4, 7. This occurs when iron deficiency coexists with B12/folate deficiency.

Common Pitfalls to Avoid

1. Don't assume dietary insufficiency alone: Even with positive dietary history, complete GI evaluation may be needed to identify malabsorption 7

2. Don't miss functional B12 deficiency: Serum B12 may be low-normal (200-400 pg/mL) but MMA and homocysteine will be elevated 1, 5

3. Don't overlook MDS in older patients: If megaloblastic changes persist despite vitamin replacement, bone marrow evaluation is mandatory 3

4. Don't ignore macrocytosis without anemia: 20.9% of B12-deficient patients present with isolated macrocytosis before anemia develops 2

5. Inflammation can mask deficiency: Ferritin may be falsely elevated in inflammatory states, obscuring coexistent iron deficiency 4

Treatment Implications

Once etiology is confirmed:

• B12 deficiency: Requires parenteral B12 initially (1000 mcg IM) if neurological symptoms present or severe deficiency
• Folate deficiency: Oral supplementation, but never treat without checking B12 first (can worsen neurological complications)
• MDS: Requires hematology referral for supportive care and potential disease-modifying therapy

The goal is hemoglobin increase of ≥2 g/dL within 4 weeks of appropriate treatment 4.